Credit Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 3.00 M
- Revenue Growth 22.02%
- Profit Growth -1256.01%
- Ebitda -23.01%
- Net Worth -11.28%
- Total Assets -13.48%
About Credit Pharmaceuticals
Credit Pharmaceuticals Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 May 2009 and has a history of 15 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M.
Vineet Singh, Prakash Singh, and Harendra Singh serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24233DL2009PTC190458
-
Company No.
190458
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 May 2009
-
Date of AGM
29 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Credit Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Singh
|
Director | 10-May-2012 | Current |
|
Vineet Singh
|
Director | 10-May-2012 | Current |
|
Harendra Singh
|
Director | 20-May-2009 | Current |
Financial Performance of Credit Pharmaceuticals.
Credit Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 22.02% increase. The company also saw a substantial fall in profitability, with a 1256.01% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Credit Pharmaceuticals?
In 2017, Credit Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Swaminath Mineral Private LimitedVineet Singh, Prakash Singh and 1 more are mutual person
-
Volkscure Private Limited
Prakash Singh is a mutual person
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Allahabad Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jun 2014 | Allahabad Bank | ₹3.00 M | Open |
How Many Employees Work at Credit Pharmaceuticals?
Unlock and access historical data on people associated with Credit Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Credit Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Credit Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
